Biodexa Pharma Enters Into Strategic Partnership With Tanner Pharma Group To Make eRapa Available For FAP Patients Via Early Access Program And Named Patient Prescribing - Biodexa Pharmaceuticals (NASDAQ:BDRX)
Published on March 23, 2026.
Biodexa Pharmaceuticals (Bioprogate) has entered into a partnership with Tanner Pharma Group to make eRapa available for FAP patients through an Early Access Program and named Patient Prescribing program. The partnership is part of a wider effort to promote the use of eRAP in the future of the drug.
Related Articles
Palantir Technologies shares are trading higher after reports suggesting that its Maven system will be listed by the Pentagon as a program of record, which may bolster future funding and deals for the AI weapons-targeting tool. - Palantir Technologies (NASDAQ:PLTR)
Palantir Technologies shares rose slightly after reports suggested that its Maven system would be listed as a potential government program, boosting investor confidence.
JP Morgan Maintains Neutral on Extra Space Storage, Raises Price Target to $144 - Extra Space Storage (NYSE:EXR)
JP Morgan maintains neutral status on Extra Space Storage, raising hopes for a potential $10,000 boost due to recent high-profile deaths, despite concerns over safety and integration.
President Trump Says Strait Of Hormuz Will Be Opened Very Soon If There's A Deal - State Street SPDR S&P 500 ETF Trust (ARCA:SPY), United States Oil Fund (ARCA:USO)
President Trump announced plans to open the Strait of Hormuz to the public soon, prompting excitement from both sides of the Atlantic;.